Brief: FDA Hologic Removes Biozorb 3D Bioabsorbable Markers Due To Risk For Patient Complications

Hologic

18/12/2024 15:05

Dec 18 (Reuters) - Hologic Inc  HOLX.O :
    * FDA: HOLOGIC REMOVES BIOZORB 3D BIOABSORBABLE MARKERS DUE
TO
RISK FOR PATIENT COMPLICATIONS
    * FDA: THERE HAVE BEEN 252 REPORTED INJURIES RELATED TO
HOLOGIC'S
BIOZORB 3D BIOABSORBABLE MARKERS
    * FDA: IDENTIFIED HOLOGIC'S RECALL AS MOST SERIOUS TYPE;
RECALL
INVOLVES REMOVING DEVICES FROM WHERE THEY ARE USED/SOLD

Source text:  ID: 
Further company coverage:  HOLX.O 

 ((Reuters.Briefs@thomsonreuters.com;))